Abstract
Parvovirus B19 (PV-B19) is a single-stranded DNA virus replicating within human erythroid progenitor cells. Infection in immunocompromised patients can cause a prolonged impairment of erythropoiesis, which manifests as anemia and reticulocytopenia due to red cell aplasia [1]. Though less common, chronic PV-B19 infection in immunocompromised hosts can also present with leukopenia and thrombocytopenia [2].
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol. 1997;53(3):229–32. https://doi.org/10.1002/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A.
Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med. 2007;131(5):799–804. https://doi.org/10.5858/2007-131-799-PBIITI.
Porignaux R, Vuiblet V, Barbe C, et al. Frequent occurrence of parvovirus B19 DNAemia in the first year after kidney transplantation. J Med Virol. 2013;85(6):1115–21. https://doi.org/10.1002/jmv.23557.
Teruel JL, Lamas S, Vila T, et al. Serum ferritin levels after renal transplantation: a prospective study. Nephron. 1989;51(4):462–5. https://doi.org/10.1159/000185376.
Gafter-Gvili A, Gafter U. Posttransplantation anemia in kidney transplant recipients. Acta Haematol. 2019;142(1):37–43. https://doi.org/10.1159/000496140.
Eid AJ, Ardura MI, AST Infectious diseases Community of Practice. Human parvovirus B19 in solid organ transplantation: guidelines from the American society of transplantation infectious diseases community of practice. Clin Transpl 2019;33(9):e13535. https://doi.org/10.1111/ctr.13535.
Cossart YE, Field AM, Cant B, Widdows D. Parvovirus-like particles in human sera. Lancet Lond Engl. 1975;1(7898):72–3. https://doi.org/10.1016/s0140-6736(75)91074-0.
Bieri J, Ros C. Globoside is dispensable for parvovirus B19 entry but essential at a Postentry step for productive infection. J Virol. 2019;93(20):e00972–19. https://doi.org/10.1128/JVI.00972-19.
Corcoran A, Doyle S. Advances in the biology, diagnosis and host–pathogen interactions of parvovirus B19. J Med Microbiol. 2004;53(6):459–75. https://doi.org/10.1099/jmm.0.05485-0.
Flunker G, Peters A, Wiersbitzky S, Modrow S, Seidel W. Persistent parvovirus B19 infections in immunocompromised children. Med Microbiol Immunol (Berl). 1998;186(4):189–94. https://doi.org/10.1007/s004300050063.
Pure Red-Cell Aplasia of 10 Years’ Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin Therapy. NEJM. https://www-nejm-org.ezproxy.library.wisc.edu/doi/10.1056/NEJM198908243210807. Accessed 3 February 2022
Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40–8. https://doi.org/10.1086/504812.
Gosset C, Viglietti D, Hue K, Antoine C, Glotz D, Pillebout E. How many times can parvovirus B19-related anemia recur in solid organ transplant recipients? Transpl Infect Dis. 2012;14(5):E64–70. https://doi.org/10.1111/j.1399-3062.2012.00773.x.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Nadeem, H., Aziz, F. (2022). Post-Transplant Parvovirus B19 Infection. In: Aziz, F., Parajuli, S. (eds) Complications in Kidney Transplantation. Springer, Cham. https://doi.org/10.1007/978-3-031-13569-9_35
Download citation
DOI: https://doi.org/10.1007/978-3-031-13569-9_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-13568-2
Online ISBN: 978-3-031-13569-9
eBook Packages: MedicineMedicine (R0)